Novel drug modalities blocking SARS-CoV-2 infection
| Reference number | |
| Coordinator | Chalmers Tekniska Högskola AB - Div. of Systems & Synthetic Biology, Dept. of Biology and Biological Engineering |
| Funding from Vinnova | SEK 4 285 177 |
| Project duration | October 2020 - December 2022 |
| Status | Completed |
| Venture | Collaborative projects for research and innovation associated to the corona pandemic |
Important results from the project
Within this project we were able to develop a new drug discovery screening platform to find potent drug candidates targeting SARS-CoV2 infection.
Expected long term effects
The project enabled us to conduct a high throughput screen to find potential drug hits targeting SARS-CoV2 infection.
Approach and implementation
The project was structured according to specific work packages including development of respective synthetic biology tools, conducting of high throughput screening, analysis of the created data sets and hit evaluation.